QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)

Taysha Gene Therapies (TSHA) Earnings Date, Estimates & Call Transcripts

$2.45
+0.16 (+6.99%)
(As of 02/27/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

TSHA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TSHA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Taysha Gene Therapies Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.69) EPS
Next Year EPS Consensus Estimate: ($0.45) EPS

TSHA Earnings Date and Information

Taysha Gene Therapies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates.

Taysha Gene Therapies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/26/2024
Estimated)
------- 
11/14/2023Q3 2023($0.13)($0.13)-$0.67$2.65 million$4.75 million
8/14/2023Q2 2023($0.31)($0.38)($0.07)($0.38)$2.00 million$2.40 million
5/11/2023Q1 2023($0.39)($0.28)+$0.11($0.28)-$4.71 million
3/28/2023Q4 2022($0.41)($0.99)($0.58)($0.99)-$2.50 million
11/8/2022Q3 2022($0.89)($0.64)+$0.25($0.64)--
8/11/2022Q2 2022($1.05)($0.84)+$0.21($0.84)--
5/16/2022Q1 2022($1.04)($1.31)($0.27)($1.31)--    
3/31/2022Q4 2021($1.21)($1.32)($0.11)($1.32)--    
11/10/2021Q3 2021($1.02)($1.35)($0.33)($1.35)--    
8/16/2021Q2 2021($0.84)($1.09)($0.25)($1.09)--    
5/11/2021Q1 2021($0.54)($0.87)($0.33)($0.87)--  
3/2/2021Q4 2020($0.36)($1.04)($0.68)---  












Taysha Gene Therapies Earnings - Frequently Asked Questions

When is Taysha Gene Therapies's earnings date?

Taysha Gene Therapies has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off last year's report dates. Learn more on TSHA's earnings history.

How much revenue does Taysha Gene Therapies generate each year?

Taysha Gene Therapies (NASDAQ:TSHA) has a recorded annual revenue of $14.35 million.

How much profit does Taysha Gene Therapies generate each year?

Taysha Gene Therapies (NASDAQ:TSHA) has a recorded net income of -$166.01 million. TSHA has generated -$2.58 earnings per share over the last four quarters.

What is Taysha Gene Therapies's EPS forecast for next year?

Taysha Gene Therapies's earnings are expected to grow from ($0.69) per share to ($0.45) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:TSHA) was last updated on 2/27/2024 by MarketBeat.com Staff